These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12784879)

  • 21. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.
    Kerkhof M; Tans PL; Hagenbeek RE; Lycklama À Nijeholt GJ; Holla FK; Postma TJ; Straathof CS; Dirven L; Taphoorn MJ; Vos MJ
    CNS Oncol; 2017 Oct; 6(4):297-306. PubMed ID: 28984142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced magnetic resonance imaging of the physical processes in human glioblastoma.
    Kalpathy-Cramer J; Gerstner ER; Emblem KE; Andronesi O; Rosen B
    Cancer Res; 2014 Sep; 74(17):4622-4637. PubMed ID: 25183787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Ioani H; Susman S; Petrescu M; Timis T; Cernea D; Kacso G; Irimie A; Florian IS
    J BUON; 2010; 15(3):583-91. PubMed ID: 20941832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.
    Nelson SJ
    NMR Biomed; 2011 Jul; 24(6):734-49. PubMed ID: 21538632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
    Shiroishi MS; Boxerman JL; Pope WB
    Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical presentation and progression of glioblastoma multiforme in a 6-year-old girl: multidisciplinary case report.
    Jahraus CD; Dishop MK; Bayliff SL; Lee C; St Clair WH
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):243-7. PubMed ID: 12621245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.
    Jovanovic M; Radenkovic S; Stosic-Opincal T; Lavrnic S; Gavrilovic S; Lazovic-Popovic B; Soldatovic I; Maksimovic R
    J BUON; 2017; 22(4):1061-1067. PubMed ID: 28952228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.
    Maurer MH; Synowitz M; Badakshi H; Lohkamp LN; Wüstefeld J; Schäfer ML; Wiener E
    Rofo; 2013 Mar; 185(3):235-40. PubMed ID: 23196836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioblastoma multiforme arising from dysembryoplastic neuroepithelial tumor in a child in the absence of therapy.
    Chuang NA; Yoon JM; Newbury RO; Crawford JR
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e536-9. PubMed ID: 24309599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
    Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
    Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
    Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
    Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroimaging features and pathology of mixed glioblastoma--AVM complex: a case report.
    Aucourt J; Jissendi P; Kerdraon O; Baroncini M
    J Neuroradiol; 2012 Oct; 39(4):258-62. PubMed ID: 22197405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance diffusion metrics indexing high focal cellularity and sharp transition at the tumour boundary predict poor outcome in glioblastoma multiforme.
    Jamjoom AA; Rodriguez D; Rajeb AT; Manita MA; Shah KA; Auer DP
    Clin Radiol; 2015 Dec; 70(12):1400-7. PubMed ID: 26403545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
    Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
    J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implanting Glioblastoma Spheroids into Rat Brains and Monitoring Tumor Growth by MRI Volumetry.
    Löhr M; Linsenmann T; Jawork A; Kessler AF; Timmermann N; Homola GA; Ernestus RI; Hagemann C
    Methods Mol Biol; 2017; 1622():149-159. PubMed ID: 28674808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
    Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
    Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.